NEVRO CORP's ticker is and the CUSIP is 64157FAC7. A total of 26 filers reported holding NEVRO CORP in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $203,040,000 | +60.8% | 18,000,000 | +100.0% | 1.57% | -14.6% |
Q3 2021 | $126,234,000 | -59.6% | 9,000,000 | -50.0% | 1.83% | -9.7% |
Q2 2021 | $312,552,000 | +131.0% | 18,000,000 | +100.0% | 2.03% | +18.6% |
Q1 2021 | $135,324,000 | -18.2% | 9,000,000 | 0.0% | 1.71% | -3.6% |
Q4 2020 | $165,420,000 | +16.6% | 9,000,000 | 0.0% | 1.78% | -14.3% |
Q3 2020 | $141,822,000 | +16.7% | 9,000,000 | 0.0% | 2.07% | +5.2% |
Q2 2020 | $121,500,000 | – | 9,000,000 | – | 1.97% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BRAIDWELL LP | 109,251,000 | $102,018,584 | 3.22% |
Opti Capital Management, LP | 19,500,000 | $18,574 | 1.34% |
Context Capital Management, LLC | 10,702 | $10,207 | 0.82% |
PFM Health Sciences, LP | 17,500,000 | $16,341,500 | 0.77% |
LINDEN ADVISORS LP | 21,366,000 | $19,993,448 | 0.20% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 1,595,000 | $1,543,041 | 0.03% |
CAPSTONE INVESTMENT ADVISORS, LLC | 6,667,000 | $6,225,645 | 0.03% |
Rock Springs Capital Management LP | 500,000 | $472,128 | 0.01% |
LAZARD ASSET MANAGEMENT LLC | 0 | $933 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |